Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
Clinical trial NCT03317496 · TERMINATED
Trial details
- NCT number
- NCT03317496
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-21
- Primary completion
- 2021-06-07
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.